Glutathione Transferase P1: Potential Therapeutic Target in Ovarian Cancer
Chemotherapy resistance of ovarian cancer, regarded as the most lethal malignant gynecological disease, can be explained by several mechanisms, including increased activity of efflux transporters leading to decreased intracellular drug accumulation, increased efflux of the therapeutic agents from th...
Main Authors: | Petar Simic, Igor Pljesa, Lazar Nejkovic, Djurdja Jerotic, Vesna Coric, Jelena Stulic, Nenad Kokosar, Dunja Popov, Ana Savic-Radojevic, Vladimir Pazin, Marija Pljesa-Ercegovac |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/58/11/1660 |
Similar Items
-
The role of glutathione transferases in renal cell carcinoma
by: Ćorić Vesna, et al.
Published: (2016-01-01) -
Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVID
by: Marko Ercegovac, et al.
Published: (2022-05-01) -
<i>GSTO1</i>, <i>GSTO2</i> and <i>ACE2</i> Polymorphisms Modify Susceptibility to Developing COVID-19
by: Tatjana Djukic, et al.
Published: (2022-03-01) -
Glutathione S-Transferases in Cancer
by: Rahul Raj Singh, et al.
Published: (2021-04-01) -
Co-localization of GSTP1 and JNK in transitional cell carcinoma of urinary bladder
by: Marija Pljesa-Ercegovac, et al.
Published: (2010-01-01)